HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine Bryla Selected Research

NSC281612

2/2015A phase i study of DMS612, a novel bifunctional alkylating agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine Bryla Research Topics

Disease

2Neoplasms (Cancer)
01/2018 - 04/2016
1Neutropenia
01/2021
1Diarrhea
01/2021
1Fatigue
01/2021
1Astrocytoma (Pilocytic Astrocytoma)
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
02/2015

Drug/Important Bio-Agent (IBA)

2Etoposide (VP 16)FDA LinkGeneric
01/2018 - 04/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 04/2016
2belinostatIBA
01/2018 - 04/2016
1EnzymesIBA
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Histone Deacetylase InhibitorsIBA
01/2018
1NSC281612IBA
02/2015

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2018